This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Congenital Nonbullous Ichthyosiform Erythroderma
Information about Congenital Nonbullous Ichthyosiform Erythroderma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Congenital Nonbullous Ichthyosiform Erythroderma
Most recent studies have shown that Congenital Nonbullous Ichthyosiform Erythroderma shares some biological mechanisms with bullous-congenital-ichthyosiform-erythroderma-(disorder), congenital-ichthyosis, dermatologic-disorders, ectropion, erythema, exfoliative-dermatitis, harlequin-fetus, hyperkeratosis, ichthyoses, ichthyosiform-erythroderma-congenital, ichthyosis-linearis-circumflexa, ichthyosis-vulgaris, ichthyosis-x-linked, keratosis, keratosis-follicularis, psoriasis, sjogren-larsson-syndrome, skin-diseases-genetic, skin-neoplasms.
Among the many pathways, these few ones have gauged particular interests from scientists studying Congenital Nonbullous Ichthyosiform Erythroderma, and have been seen in publications frequently: Cell Cycle, Cell Death, Cell Proliferation, Cholesterol Transport, Coagulation, Cornification, Immune Response, Keratinization, Keratinocyte Differentiation, Lipid Homeostasis, Lipid Storage, Lipid Transport, Localization, Pathogenesis, Programmed Cell Death, Proteolysis, Secretion, Skin Development, Translation, Transport
Quite a number of genes have been found to play important roles in Congenital Nonbullous Ichthyosiform Erythroderma, such as ABCA12, ABCC8, ABHD5, AKAP4, ALOX12, ALOX12B, ALOXE3, CST6, FLG, GBA, IVL, KRT10, TGM1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.